Quantitative proteomics analysis of zebrafish exposed to sub-lethal dosages of β-methyl-amino-L-alanine (BMAA)

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Frøyset, Ann Kristin ^a   Khan, Essa Ahsan ^a   Fladmark, Kari Espolin ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA-N-METHYLAMINO-L-ALANINE; DIAMINO ACID; FISH PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL; HEART RATE; METABOLISM; PROTEOMICS; ZEBRA FISH;

AMINO ACIDS, DIAMINO; ANIMALS; FISH PROTEINS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HEART RATE; PROTEOMICS; ZEBRAFISH;

EID: 84978849189     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29631     Document Type: Article

References (52)

1. Cox, P. A. et al. Diverse taxa of cyanobacteria produce beta-N-methylamino-L-alanine, a neurotoxic amino acid. Proceedings of the National Academy of Sciences of the United States of America 102, 5074-5078, doi: 10.1073/pnas.0501526102 (2005).
2. Jiang, L. et al. Diatoms: a novel source for the neurotoxin BMAA in aquatic environments. PloS one 9, e84578, doi: 10.1371/journal. pone.0084578 (2014).
3. Murch, S. J., Cox, P. A., Banack, S. A., Steele, J. C., Sacks, O. W. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta neurologica Scandinavica 110, 267-269, doi: 10.1111/j.1600-0404.2004.00320.x (2004).
4. Hirano, A., Malamud, N., Elizan, T. S., Kurland, L. T. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. Archives of neurology 15, 35-51 (1966).
5. Cox, P. A., Sacks, O. W. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 58, 956-959 (2002).
6. Banack, S. A. et al. Detection of cyanotoxins, beta-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis. Toxins 7, 322-336, doi: 10.3390/toxins7020322 (2015).
7. Masseret, E. et al. Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France. PloS one 8, e83406, doi: 10.1371/journal.pone.0083406 (2013).
8. Pablo, J. et al. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta neurologica Scandinavica 120, 216-225, doi: 10.1111/j.1600-0404.2008.01150.x (2009).
9. Jonasson, S. et al. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proceedings of the National Academy of Sciences of the United States of America 107, 9252-9257, doi: 10.1073/pnas.0914417107 (2010).
10. Ross, S. M., Seelig, M., Spencer, P. S. Specific antagonism of excitotoxic action of 'uncommon' amino acids assayed in organotypic mouse cortical cultures. Brain research 425, 120-127 (1987).
11. Lobner, D., Piana, P. M., Salous, A. K., Peoples, R. W. Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiology of disease 25, 360-366, doi: 10.1016/j.nbd.2006.10.002 (2007).
12. Dunlop, R. A., Cox, P. A., Banack, S. A., Rodgers, K. J. The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregation. PloS one 8, e75376, doi: 10.1371/journal.pone.0075376 (2013).
13. Karlsson, O., Berg, C., Brittebo, E. B., Lindquist, N. G. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells-a possible link between Parkinson-dementia complex and pigmentary retinopathy. Pigment cell & melanoma research 22, 120-130, doi: 10.1111/j.1755-148X.2008.00508.x (2009).
14. Nunn, P. B., O'Brien, P. The interaction of beta-N-methylamino-L-alanine with bicarbonate: an 1H-NMR study. FEBS letters 251, 31-35 (1989).
15. Rao, S. D., Banack, S. A., Cox, P. A., Weiss, J. H. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Experimental neurology 201, 244-252, doi: 10.1016/j.expneurol.2006.04.017 (2006).
16. Liu, X., Rush, T., Zapata, J., Lobner, D. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-). Experimental neurology 217, 429-433, doi: 10.1016/j.expneurol.2009.04.002 (2009).
17. Arif, M., Kazim, S. F., Grundke-Iqbal, I., Garruto, R. M., Iqbal, K. Tau pathology involves protein phosphatase 2A in parkinsonismdementia of Guam. Proceedings of the National Academy of Sciences of the United States of America 111, 1144-1149, doi: 10.1073/pnas.1322614111 (2014).
18. Munoz-Saez, E. et al. beta-N-methylamino-L-alanine induces changes in both GSK3 and TDP-43 in human neuroblastoma. The Journal of toxicological sciences 38, 425-430 (2013).
19. de Munck, E. et al. Morphometric and neurochemical alterations found in l-BMAA treated rats. Environmental toxicology and pharmacology 39, 1232-1245, doi: 10.1016/j.etap.2015.04.022 (2015).
20. Cox, P. A., Davis, D. A., Mash, D. C., Metcalf, J. S., Banack, S. A. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proceedings. Biological sciences/The Royal Society 283, doi: 10.1098/rspb.2015.2397 (2016).
21. Okle, O., Stemmer, K., Deschl, U., Dietrich, D. R. L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations. Toxicological sciences: an official journal of the Society of Toxicology 131, 217-224, doi: 10.1093/toxsci/kfs291 (2013).
22. Main, B. J., Dunlop, R. A., Rodgers, K. J. The use of l-serine to prevent beta-methylamino-l-alanine (BMAA)-induced proteotoxic stress in vitro. Toxicon: official journal of the International Society on Toxinology 109, 7-12, doi: 10.1016/j.toxicon.2015.11.003 (2016).
23. Newman, M., Ebrahimie, E., Lardelli, M. Using the zebrafish model for Alzheimer's disease research. Frontiers in genetics 5, 189, doi: 10.3389/fgene.2014.00189 (2014).
24. Xi, Y., Noble, S., Ekker, M. Modeling neurodegeneration in zebrafish. Current neurology and neuroscience reports 11, 274-282, doi: 10.1007/s11910-011-0182-2 (2011).
25. Haug, M. F., Gesemann, M., Mueller, T., Neuhauss, S. C. Phylogeny and expression divergence of metabotropic glutamate receptor genes in the brain of zebrafish (Danio rerio). The Journal of comparative neurology 521, 1533-1560, doi: 10.1002/cne.23240 (2013).
26. Cox, J. A., Kucenas, S., Voigt, M. M. Molecular characterization and embryonic expression of the family of N-methyl-D-aspartate receptor subunit genes in the zebrafish. Developmental dynamics: an official publication of the American Association of Anatomists 234, 756-766, doi: 10.1002/dvdy.20532 (2005).
27. Purdie, E. L., Samsudin, S., Eddy, F. B., Codd, G. A. Effects of the cyanobacterial neurotoxin beta-N-methylamino-L-alanine on the early-life stage development of zebrafish (Danio rerio). Aquatic toxicology 95, 279-284, doi: 10.1016/j.aquatox.2009.02.009 (2009).
28. Munoz-Saez, E. et al. Analysis of beta-N-methylamino-L-alanine (L-BMAA) neurotoxicity in rat cerebellum. Neurotoxicology 48, 192-205, doi: 10.1016/j.neuro.2015.04.001 (2015).
29. Munoz-Saez, E. et al. Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y). Neuroscience letters 593, 83-89, doi: 10.1016/j.neulet.2015.03.010 (2015).
30. Garafalo, S. D. et al. The AP2 clathrin adaptor protein complex regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of Caenorhabditis elegans. Molecular biology of the cell 26, 1887-1900, doi: 10.1091/mbc.E14-06-1048 (2015).
31. Ohno-Shosaku, T., Kano, M. Endocannabinoid-mediated retrograde modulation of synaptic transmission. Current opinion in neurobiology 29, 1-8, doi: 10.1016/j.conb.2014.03.017 (2014).
32. Mao, L. M., Jin, D. Z., Xue, B., Chu, X. P., Wang, J. Q. Phosphorylation and regulation of glutamate receptors by CaMKII. Sheng li xue bao: [Acta physiologica Sinica] 66, 365-372 (2014).
33. Wang, M. et al. Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity. Molecular brain 5, 13, doi: 10.1186/1756-6606-5-13 (2012).
34. Humphries, J. D. et al. Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Science signaling 2, ra51, doi: 10.1126/scisignal.2000396 (2009).
35. Zheng, N., Jeyifous, O., Munro, C., Montgomery, J. M., Green, W. N. Synaptic activity regulates AMPA receptor trafficking through different recycling pathways. eLife 4, doi: 10.7554/eLife.06878 (2015).
36. Costanzo, R. V. et al. Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis. The European journal of neuroscience 23, 309-324, doi: 10.1111/j.1460-9568.2005.04555.x (2006).
37. Marza, E. et al. Genome-wide screen identifies a novel p97/CDC-48-dependent pathway regulating ER-stress-induced gene transcription. EMBO reports 16, 332-340, doi: 10.15252/embr.201439123 (2015).
38. Csont, T. et al. Tissue-specific Gene Expression in Rat Hearts and Aortas in a Model of Vascular Nitrate Tolerance. Journal of cardiovascular pharmacology 65, 485-493, doi: 10.1097/FJC.0000000000000218 (2015).
39. Gong, X., Ivanov, V. N., Hei, T. K. 2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-kappaB, AP-1 and MAPK pathways in human proximal tubular cells. Archives of toxicology, doi: 10.1007/s00204-015-1600-z (2015).
40. Adachi, T., Matsumoto, Y., Inagaki, Y., Sekimizu, K. Niemann-Pick disease type C2 protein induces autophagy and inhibits growth in FM3A breast cancer cells. Drug discoveries & therapeutics 9, 282-288, doi: 10.5582/ddt.2015.01014 (2015).
41. Shephard, F., Greville-Heygate, O., Marsh, O., Anderson, S., Chakrabarti, L. A mitochondrial location for haemoglobins-dynamic distribution in ageing and Parkinson's disease. Mitochondrion 14, 64-72, doi: 10.1016/j.mito.2013.12.001 (2014).
42. Buee-Scherrer, V. et al. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. The American journal of pathology 146, 924-932 (1995).
43. Erickson, J. R. et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462-474, doi: 10.1016/j.cell.2008.02.048 (2008).
44. Fladmark, K. E. et al. Ca2dependent protein kinase II is required for microcystin-induced apoptosis. The Journal of biological chemistry 277, 2804-2811, doi: 10.1074/jbc.M109049200 (2002).
45. Shah, S. A., Lee, H. Y., Bressan, R. A., Yun, D. J., Kim, M. O. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain. Cell death & disease 5, e1026, doi: 10.1038/cddis.2013.538 (2014).
46. Bilsland, L. G. et al. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 20, 1003-1005, doi: 10.1096/fj.05-4743fje (2006).
47. More, S. V., Choi, D. K. Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection. Molecular neurodegeneration 10, 17, doi: 10.1186/s13024-015-0012-0 (2015).
48. Zhai, D., Li, S., Wang, M., Chin, K., Liu, F. Disruption of the GluR2/GAPDH complex protects against ischemia-induced neuronal damage. Neurobiology of disease 54, 392-403, doi: 10.1016/j.nbd.2013.01.013 (2013).
49. Fukuhara, Y. et al. GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+induced apoptosis. Neuroreport 12, 2049-2052 (2001).
50. Travers, K. J. et al. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101, 249-258 (2000).
51. Nataf, S., Pays, L. Gene co-expression analysis unravels a link between C9orf72 and RNA metabolism in myeloid cells. Acta neuropathologica communications 3, 64, doi: 10.1186/s40478-015-0242-y (2015).
52. Wisniewski, J. R., Zougman, A., Nagaraj, N., Mann, M. Universal sample preparation method for proteome analysis. Nature methods 6, 359-362, doi: 10.1038/nmeth.1322 (2009).